Cargando…

Response of patients with sickle cell anaemia and end-stage renal disease to erythropoietin treatment

Detalles Bibliográficos
Autor principal:	Zumrutdal, Aysegul
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2010
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3121217/ https://www.ncbi.nlm.nih.gov/pubmed/21709764 http://dx.doi.org/10.1093/ndtplus/sfq011

Ejemplares similares

Erythropoietin and renal protection
por: Baradaran, Azar, et al.
Publicado: (2013)

Soluble Erythropoietin Receptor Contributes to Erythropoietin Resistance in End-Stage Renal Disease
por: Khankin, Eliyahu V., et al.
Publicado: (2010)

Avascular necrosis of left Hip joint secondary to sickle cell anaemia for hip arthroplasty
por: Borkar, Sharmila, et al.
Publicado: (2015)

Metabolic syndrome in end stage renal disease
por: Mortazavi, Mojgan, et al.
Publicado: (2014)

End-stage Renal Disease in Griscelli Syndrome
por: Mahajan, Vidushi, et al.
Publicado: (2022)

Gadolinium-based contrast agents, erythropoietin and nephrogenic systemic fibrosis in patients with end-stage renal failure
por: Pieringer, Herwig, et al.
Publicado: (2008)

Combined Cardiac Impairments in End-Stage Renal Disease
por: Sobieszczańska, Małgorzata, et al.
Publicado: (2012)

Comment on the Paper Entitled ‘Erythropoietin Ameliorates Oxidative Stress and Tissue Injury following Renal Ischemia/Reperfusion in Rat Kidney and Lung’
por: Aydin, Mustafa, et al.
Publicado: (2014)

Renal Cell Protection of Erythropoietin beyond Correcting The Anemia in Chronic Kidney Disease Patients
por: Nasri, Hamid
Publicado: (2014)

Congenital nephrogenic diabetes insipidus with end-stage renal disease
por: Ryu, Hyun Ho, et al.
Publicado: (2015)

Refractory Hypercalcemia in a Patient with End Stage Renal Disease
por: Prabhahar, Arun, et al.
Publicado: (2022)

Effect of Periodic Transfusion on Erythropoietin Concentration in End Stage Renal Disease
por: Hong, Sae Yong, et al.
Publicado: (1992)

V-J combinations of T-cell receptor predict responses to erythropoietin in end-stage renal disease patients
por: Wong, Henry Sung-Ching, et al.
Publicado: (2017)

Treatment of anaemia in end-stage renal disease: A double-edged iron sword?
por: Chinnadurai, Rajkumar, et al.
Publicado: (2019)

The sickle cell trait and end stage renal disease in Salvador, Brazil
por: Alladagbin, Dona J., et al.
Publicado: (2018)

Comment on: Oxygen gradient ektacytometry does not predict pain in children with sickle cell anaemia
por: Sheehan, Vivien A., et al.
Publicado: (2022)

Sarcomatoid Renal Cell Carcinoma in an Adolescent with Sickle Cell Anaemia
por: Ahmad, H. R., et al.
Publicado: (2017)

Several factors can alter the QTc interval in patients with end-stage renal disease
por: Gülgün, Mustafa
Publicado: (2016)

End-Stage renal disease and 30-day mortality for adults with and without COVID-19
por: Harrison, Stephanie L., et al.
Publicado: (2021)

Establishment of Reference Values for Non-HLA Antibodies in Patients With End-stage Renal Disease
por: Shin, Kyung-Hwa, et al.
Publicado: (2023)

Sickle Cell Anaemia: Progress in Pathogenesis and Treatment
por: Ballas, Samir K.
Publicado: (2012)

Coronary microvascular dysfunction is associated with degree of anaemia in end‐stage renal disease
por: Radhakrishnan, Ashwin, et al.
Publicado: (2021)

Sickle Cell Anaemia and Malaria
por: Luzzatto, Lucio
Publicado: (2012)

Sickle Cell Anæmia in India
Publicado: (1952)

Distinct B and NKT cell responses shape the delayed response to ChAdOx1 nCoV-19 vaccine in end-stage renal disease
por: Putri, Denise Utami, et al.
Publicado: (2022)

Comment on “Economic Burden and Medical Insurance Impact of the Different Dialysis for End-Stage Renal Diseases”
por: Bayati, Mohsen
Publicado: (2019)

Iron Chelation Therapy With Deferasirox in Sickle Cell Disease With End-Stage Renal Disease
por: Raj, Ashok, et al.
Publicado: (2022)

Ocular manifestations of sickle cell disease
por: Joob, Beuy, et al.
Publicado: (2018)

Surgical treatment of anaemia – is it possible? Large hiatal hernia as a cause of severe iron-deficiency anaemia
por: Feret, Wiktoria B., et al.
Publicado: (2022)

Diastolic dysfunction in end-stage renal disease patient: what the ticking clock has told us?
por: Chao, Chia-Ter
Publicado: (2011)

Diastolic dysfunction in end-stage renal disease patient: what the ticking clock has told us?
por: Duran, Mustafa, et al.
Publicado: (2011)

Unusual finding of cellular glomeruli infiltrated with lymphocytes in end stage renal disease due to obstructive nephropathy
por: Gaopande, V. L., et al.
Publicado: (2014)

Simultaneous pancreas-kidney transplantation for diabetic end-stage renal disease under a hypertension status
por: Xu, Shengqian, et al.
Publicado: (2015)

Erythropoietin, uncertainty principle and cancer related anaemia
por: Clark, Otavio, et al.
Publicado: (2002)

Urban and rural population comparison of hepatic profile and associated etiology among children with end-stage renal disease
por: Shah, S. R., et al.
Publicado: (2016)

Hyperglycemic hyperosmolar state associated with invasive rhino-orbital aspergillosis in a patient with end-stage renal disease
por: Seo, Ju Hyun, et al.
Publicado: (2017)

A few comments about the evaluation for small and diminutive colorectal polyps in end-stage renal disease patients
por: Lei, Tiantian, et al.
Publicado: (2022)

Sickle Cell Disease and Bartonella Spp. Infection
por: Velho, Paulo Eduardo Neves Ferreira, et al.
Publicado: (2012)

Madhya Pradesh sickle cell mission: An initiative for screening, counseling and treatment of sickle cell disorders among tribal communities
por: Bijlwan, Aanchal, et al.
Publicado: (2022)

Preventive role of erythropoietin against aminoglycoside renal toxicity induced nephropathy; current knowledge and new concepts
por: Rafieian-Kopaei, Mahmoud, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_3149btbo9vm0cbt79g9u7pr19v